References for Enhancing Motivation for Change in Substance Use Disorder Treatment – Part 1

Acevedo, Andrea, Nellie Harvey, Maureen Kamanu, Shalini Tendulkar, and Sasha Fleary. 2020. “Barriers, Facilitators, and Disparities in Retention for Adolescents in Treatment for Substance Use Disorders: A Qualitative Study with Treatment Providers.” Substance Abuse Treatment, Prevention, and Policy 15 (1): 1-13.
Ahmed, Saeed, Ramya Bachu, Padma Kotapati, Mahwish Adnan, Rizwan Ahmed, Umer Farooq, Hina Saeed, Ali Mahmood Khan, Aarij Zubair, and Iqra Qamar. 2019. “Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review.” Frontiers in Psychiatry 10: 228.
Back, Sudie E., Therese Killeen, Christal L. Badour, Julianne C. Flanagan, Nicholas P. Allan, Elizabeth Santa Ana, Brian Lozano, Kristina J. Korte, Edna B. Foa, and Kathleen T. Brady. 2019. “Concurrent Treatment of Substance Use Disorders and PTSD Using Prolonged Exposure: A Randomized Clinical Trial in Military Veterans.” Addictive Behaviors 90: 369-377.
Bacon, Melody. 2019. Family Therapy and the Treatment of Substance Use Disorders: The Family Matters Model.
Blunt, Elson Oshman, Johanna Catherine Maclean, Ioana Popovici, and Steven C Marcus. 2020. “Public Insurance Expansions and Mental Health Care Availability.” HESR Health Services Research 55 (4): 615-25.
Chye, Yann, Erynn Christensen, Nadia Solowij, and Murat Yacel. 2019. “The Endocannabinoid System and Cannabidiol’s Promise for the Treatment of Substance Use Disorder.” Frontiers in Psychiatry 10: 63.
Coco, Gianluca Lo, Francesco Melchiori, Veronica Oieni, Maria Rita Infurna, Bernhard Strauss, Dominique Schwartze, Jenny Rosendahl, and Salvatore Gullo. 2019. “Group Treatment for Substance Use Disorder in Adults: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.” Journal of Substance Abuse Treatment 99: 104-116.
Colvonen, Peter J., Jennifer Ellison, Moira Haller, and Sonya B. Norman. 2019. “Examining Insomnia and PTSD over Time in Veterans in Residential Treatment for Substance Use Disorders and PTSD.” Behavioral Sleep Medicine 17 (4): 524-535.
Kiluk, Brian D., Garrett M. Fitzmaurice, Eric C. Strain, and Roger D. Weiss. 2019. “What Defines a Clinically Meaningful Outcome in the Treatment of Substance Use Disorders: Reductions in Direct Consequences of Drug Use or Improvement in Overall Functioning?” Addiction 114 (1): 9-15.
Mojtabai, Ramin, Christine Mauro, Melanie M. Wall, Colleen L. Barry, and Mark Olfson. 2019. “Medication Treatment for Opioid Use Disorders in Substance Use Treatment Facilities.” Health Affairs 38 (1): 14-23.
Oregon, Division of Financial Regulation, Oregon, and Legislative Assembly. 2018. Report on existing barriers to effective treatment for and recovery from substance use disorders, including addictions to opioids and opiates.
Thomson, Mary. 2018. Assessment And Treatment Of Substance Use Disorders. US: Tritech Digital Media.